title: Digoxin: quo vadis?
authors.forename: John G F
authors.initials: JG
authors.lastname: Cleland
authors.forename: Damien
authors.initials: D
authors.lastname: Cullington
mesh_terms: D002309:Cardiology / Q000639:trends*; D002316:Cardiotonic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004077:Digoxin / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D011379:Prognosis; D012720:Severity of Illness Index; D016276:Ventricular Function / Q000187:drug effects
chemical_list: D002316:Cardiotonic Agents; D004077:Digoxin